Biotinidase deficiency: novel mutations and their biochemical and clinical correlates.

Barry Wolf*, Kevin P. Jensen, Bruce Barshop, Miriam Blitzer, Martha Carlson, David R. Goudie, Gulden Huner Gokcay, Mubeccel Demirkol, Tolunay Baykal, F. Demir, Sharon Quary, Ling Yu Shih, Helio F. Pedro, Tsui Hua H. Chen, Alfred E. Slonim

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Biotinidase deficiency is a defect in the recycling of the vitamin biotin. Biotin supplementation can markedly improve the neurological and cutaneous symptoms of affected children and prevent symptoms in children identified by newborn screening or treated since birth. We have determined thirteen novel mutations in children with the disorder. Two nonsense mutations, eight single missense mutations, three allelic double missense mutations, and two are polymorphisms were identified in the biotinidase gene (BTD). One of the missense mutations, c.734G>A (p. C245Y), is the first to be reported that alters the cysteine in the putative location crucial for ester formation and binding of the biotinyl-moiety in the active site of the enzyme. These mutations add to the growing list of mutations that are helping to delineate structure/function relationships of the enzyme.

Original languageEnglish (US)
Pages (from-to)413
Number of pages1
JournalHuman mutation
Issue number4
StatePublished - Apr 2005

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Biotinidase deficiency: novel mutations and their biochemical and clinical correlates.'. Together they form a unique fingerprint.

Cite this